Research and Markets: Contraception Market Report 2007.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c67505) has announced the addition of Contraception Market Report 2007 to their offering. The UK market for contraceptives, as evaluated in this report, comprises four main sectors: hormone-based products; barrier products; intra-uterine device (IUD IUD Definition An IUD is an intrauterine device made of plastic and/or copper that is inserted into the womb (uterus) by way of the vaginal canal. One type releases a hormone (progesterone), and is replaced each year. ) products and other methods. Hormone-based products is a publicly funded sector, is the largest sector, having overtaken barrier products, which was the largest sector in 2004. The former continues to perform well, particularly with oral contraceptives Oral Contraceptives Definition Oral contraceptives are medicines taken by mouth to help prevent pregnancy. They are also known as the Pill, OCs, or birth control pills. , while the latter is currently experiencing difficulties in terms of deflationary pressure on prices, which is affecting value levels. The total market was worth PS164.5m in 2007, which is not a huge sum in comparison with other sectors within the pharmaceutical market. This is a low-revenue industry with a fairly saturated, slow-growing consumer base of mainly women. There is not much incentive for new product development (NPD NPD New Product Development NPD Nouveau Parti Démocratique (Canada) NPD Narcissistic Personality Disorder NPD Norwegian Petroleum Directorate NPD Nationaldemokratische Partei Deutschlands -- although it is happening) and it is telling that the most popular oral contraceptive oral contraceptive n. A pill, typically containing estrogen or progesterone, that prevents conception or pregnancy. Also called birth control pill. , Microgynon, was introduced onto the UK market during the 1960s. New products -- such as the combined pill Yasmin, from Schering Health and the progestogen-only pill Cerazette, from Organon or·ga·non or or·ga·num n. pl. or·ga·nons or or·ga·nums or or·ga·na 1. An organ. 2. A set of principles for use in scientific investigation. organon pl. organa [Gr.] organ. -- have tended to take market share from other products, rather than to stimulate the sector as a whole. Society is changing and, although levels of sexual activity have not altered much overall, people are becoming sexually active at an earlier age. This impacts on the teenage pregnancy teenage pregnancy Adolescent pregnancy, teen pregnancy Social medicine Pregnancy by a ♀, age 13 to 19; TP is usually understood to occur in a ♀ who has not completed her core education–secondary school, has few or no marketable skills, is rate, which is still the highest in Europe, and also on the occurrences of sexually transmitted infections (STIs), which are increasing at alarming rates. More education on STIs and more encouragement to use condoms, in particular, is currently a government target. This is boosting volume sales of condoms and encouraging more players to move into the sector, but revenue growth, as a whole, is currently on a downward curve within a heavily discounted market. Manufacturers of condoms have attempted to redress the loss in value through expansion of condom ranges into areas such as lubricants and massagers. In terms of the protected market, there has been a move towards long-acting reversible contraceptives (LARCs), which the National Institute for Health and Clinical Excellence “NICE” redirects here. For other uses, see NICE (disambiguation). The National Institute for Health and Clinical Excellence or NICE is a Special Health Authority of the National Health Service in England and Wales. (NICE) believes will be more effective methods, both in terms of contraception and cost, over the longer term. The Mirena intra-uterine system (IUS IUS Indiana University Southeast (New Albany, IN, USA) IUS Inertial Upper Stage IUS International Union of Students IUS Intra-Uterine System (contraception) ) which can last up to 5 years, has been particularly successful and there has been significant growth in the number of prescriptions issued in the UK over the period. Similarly, the contraceptive implant Implanon has become much more popular. With both these methods, women can effectively forget about contraception -- certainly in terms of pregnancy -- therefore, the risk of unwanted pregnancy is low. However, for the majority of young women, in particular, the pill -- and mainly the combined pill -- will continue to be the dominant form of contraception for some years to come. Nonetheless, for both men and women (again, particularly popular with younger adults), the condom is crucial to prevent STIs. Both of these sectors have an assured future -- certainly in terms of demographics -- and this stable market is firmly underpinned. Report breakdown: Executive Summary 1. Market Definition 2. Market Size 3. Industry Background 4. Competitor Analysis 5. Strengths, Weaknesses, Opportunities and Threats 6. Buying Behaviour 7. Current Issues 8. The Global Market 9. Forecasts 10. Company Profiles 11. Consumer Confidence 12. Further Sources Companies mentioned within this report: - Ansell (uk) Ltd - Janssen-cilag Ltd - Organon Laboratories Ltd - Pfizer Ltd - Schering Health Care Ltd - SSL International Plc - Association of British Pharmaceutical Industry - British Pregnancy Advisory Service The British Pregnancy Advisory Service (BPAS) is a British non-profit organisation whose stated purpose is to "[support] reproductive choice by advocating and providing high quality, affordable services to prevent or end unwanted pregnancies with contraception or by abortion. - Brook Advisory Centres - Department of Health - The NHS NHS abbr. National Health Service NHS (in Britain) National Health Service Information Centre - Family Planning Association This article is about the UK charity. For the Hong Kong organisation, see The Family Planning Association of Hong Kong. The Family Planning Association, also known as fpa, is a UK registered charity (number 250187) working to promote sexual health. - Marie Stopes International - National Institute for Health and Clinical Excellence - National Pharmaceutical Association - Royal Pharmaceutical Society of Great Britain The Royal Pharmaceutical Society of Great Britain (RPSGB) is the statutory regulatory and professional body for pharmacists and Pharmacy Technicians in England, Scotland and Wales. - Boots and Superdrug - Church & Dwight UK Ltd - Condomi Health UK Ltd - The Female Health Company (UK) PLC - FCUK FCUK French Connection United Kingdom (clothing brand) - Sexual Health Group PLC - Wyeth Europa Ltd For more information visit http://www.researchandmarkets.com/reports/c67505 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion